Dr. Jane Buchan added another feather to her cap on Wednesday by joining the Immix Biopharma board of directors.
Buchan is well known for her role in co-founding the fund of hedge funds PAAMCO in 2000. The firm grew to $32 billion in AUM during her 18 years at the helm. Her trading group spun off from PAAMCO and began operating independently as Martlet Asset Management in January 2019.
"ImmixBio is a transformative company with exceptional leadership that is working to build a world-class biopharmaceutical platform," Dr. Buchan said. "I am looking . . .
Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Monthly and annual subs available. Research articles require an Annual sub.